Acurian shortens timelines by up to 20 months for a Uterine Fibroid program
This was an important phase III, two-protocol study for a first-in-class treatment of abdominal uterine bleeding in women with uterine fibroids.
The sponsor was facing significant enrollment challenges. Site start-up was delayed; sites were unable to meet their overly optimistic commitments to deliver enough patients; many patients were unwilling to wash off their current birth control medications to participate...
Read More »